Volume 3, Jan - Mar 2020
Case Report:
Author’s Affiliation:

1- Department of Pediatrics, Bharati Vidyapeeth University Medical College Hospital & Research Centre, Pune.

Dr. Sunil V. Kapur, Email: Sunilvkapur@gmail.com Contact: 91-9930929544
Received on: 04-Jan-2020
Accepted for Publication: 17-Mar-2020
Article No: 2014lqm102506
PDF - Full Text

Infantile systemic hyalinosis is an autosomal recessive rare disorder characterized by progressive joint contractures, skin abnormalities and systemic deposition of hyaline material in many tissues. We report a three month old male child who presented with multiple joint contractures, mild gingival hypertrophy and hyperpigmented skin lesions over both hands and legs. His elder brother child also had similar findings which were progressive and he died at five years of age. Genetic testing in our patient revealed a homozygous single base deletion in the ANTXR2 gene; confirming the diagnosis of Infantile systemic hyalinosis. No specific treatment is available for infantile systemic hyalinosis. Child was treated with supportive therapy with orthopedic support. Early diagnosis of Infantile systemic hyalinosis needs an awareness of this condition which can be confirmed by genetic testing. 

Keywords: Hyalinosis, Skin involvement, ANTXR2



Infantile systemic hyalinosis (ISH) is a rare autosomal recessive disease of the connective tissue characterized by generalized deposition of hyaline material in various tissues such as skin, joints, gastrointestinal tract, adrenals, skeletal muscles, gingiva and other organs1,2,3. Gene mutations in capillary morphogenesis protein-2 also called as anthrax toxin receptor 2 (CMG2/ANTXR2) gene on chromosome 4q21 are responsible for ISH 4. Very few case reports of ANTXR2 mutation have been published in Indian population; none from Western part of India 5,6,7,8. ISH is progressive lethal disease with infants developing repeated purulent infections, diarrhea and osteoporosis in early stages of life. This is followed by hyaline infiltration of the intestinal mucosa causing protein-losing enteropathy which leads to malnutrition. The survival age may vary from two to six years based on management 2. Sepsis, respiratory and cardiac failure are common causes of mortality in these patients 9,10. We report a rare case ISH with mutation in ANTXR2 gene


A three month old male child, only living issue of a third degree consanguineous marriage was referred to rheumatology clinic with history of excessive crying on being handled with difficulty in moving his limbs and hyperpigmented skin lesions over both hands & legs. There was no history of fever, diarrhea, seizures or failure to thrive. There was history of three unexplained abortions. Older male sibling had similar manifestations and had died due to respiratory illness at the age of five years. Birth history was normal. Neck holding and social smile was present. Anthropometry was within normal limits. Clinical examination revealed absence of obvious dysmorphic facies, flexion contractures over the elbows, wrist, knees, and small joints of the fingers leading to a frog‑like position, hyperpigmented indurated plaques on the bony prominences of the metacarpo-phalangeal joints, ankle joints, metatarso-phalangeal joints (Figure 1 and 2), mild gingival hyperplasia with no evidence of hepato-splenomegaly. Hemoglobin (Hb=11.9 gm/dl, WBC=7,200/cmm; N=52%, L=48%, Platelets=267000) and ESR (12mm at the end of one hour) were within normal limits. Ophthalmology examination and 2d-ECHO were normal. X-ray of the knee joint revealed osteopenia with no erosions. Genetic testing revealed that the sample was homozygous for deletion mutation c.1256delC in exon 15 leading to premature termination of protein ANTXR2; confirming the diagnosis of ISH. Child was treated with supportive therapy with orthopedic support.


Common age of presentation of ISH is between the ages of 2 and 5 years with multiple nodular skin lesions, gingival hypertrophy, joint contractures, and osteolytic lesions on imaging11. The earliest case report of ISH based from India is two month old male child 7. Our case was also diagnosed early based on characteristic clinical features of ISH including multiple joint contractures and hyperpigmented indurated plaques over bony prominences on multiple joints. Similar to our child, ICH children are usually normal at birth. The sequence and organ involvement severity in ISH is extremely variable. The most debilitating problem in ISH are progressive flexion contractures causing a frog‑like position with inability to stand and walk 12. This is due to an apparent increase in the amount of collagen type VI 13. Dysmorphic facial feature might include deep‑set eyes, depressed nasal bridge, prominent forehead, and macrocephaly which were not present in our patient. Skin lesions in ICH are variable and may include translucent nodules on pulps of fingers, external portions of ears, and nose or small fleshy pearly papules usually near nasolabial folds, mastoid area, and neck all of which were absent in our patient 14. However, thickened hyperpigmented plaques over bony prominences of joints are a prominent feature of ISH which was seen over multiple joints in our patient. Gingival hyperplasia present in our patient can lead to poor oral hygiene, poor feeding, and dental infections. Imaging in ISH may reveal delayed skeletal maturation, osteopenia, bony erosions, and osteolytic defects 15. Hematological manifestations of ISH include low serum albumin, hypochromic, and microcytic anemia with elevated WBC count and platelet count 16.  In our patient, hemogram was within normal limits and X-ray of knee joint revealed osteopenia with no erosions. Parents did not consent for skin biopsy. Characteristic histological findings include cords of oval to spindle‑shaped cells within the PAS‑positive amorphous eosinophilic matrix, containing abundant hyaline material17. ISH diagnosis was confirmed on clinical exome analysis which revealed a homozygous single base deletion in the ANTXR2 gene. Treatment is symptomatic. Early tumor removal for nodular lesions, gingivectomy, and nutritional supplementation for gingival hypertrophy and resulting malnutrition, physiotherapy to prevent flexion contractures and intralesional corticosteroid therapy for established joint contractures are modalities used in ISH. Penicillamine, methotrexate, calcitriol, dimethylsulfoxide, and ketotifen have been tried in few cases with limited success   4, 18. Genetic counseling is an important aspect of management.


Identification of this rare condition by paediatrician is critical to facilitate an early diagnosis which in turn will lead to a betterment of prognosis.


There are no conflicts of interest


Figure 1: Hyperpigmented indurated plaques on the bony prominences of metacarpo-phalangeal joints


Figure 2: Hyperpigmented indurated plaques on the bony prominences of ankles and metatarso-phalangeal joints


  1. Buyukgebiz B, Ozturk Y, Arslan N, Ozer E. A rare cause of protein-losing enteropathy and growth retardation in infancy: infantile systemic hyalinosis. Turk J Pediatr 2003; 45: 258-60.
  2. Al-Mubarak L, Al-Makadma A, Al-Khenaizan S. Infantile systemic hyalinosis presenting as intractable infantile diarrhea. Eur J Pediatr 2009; 3:363-5.
  3. Landing BH, Nadorra R. Infantile systemic hyalinosis: report of four cases of a disease, fatal in infancy, apparently different from juvenile systemic hyalinosis. Pediatr Pathol 1986 ;6 :55-79.
  4. Dhingra M, Amladi S, Savant S, Nayak C. Juvenile hyaline fibromatosis and infantile systemic hyalinosis: Divergent expressions of the same genetic defect?. Indian J Dermatol Venereol Leprol 2008 ;74:371.
  5. Soni JP, Puri RD, Jetha K, Bhavani GS, Chaudhary M, Kohli S, Verma IC. Infantile systemic hyalinosis: Novel founder mutation in the initiation codon among `malis (farmers)` in Jodhpur. Indian J Pediatr. 2016 ;83:1341-5.
  6. Aggarwal ML, Chilakamarri V, Chennuri VS, Karra M. Identical Twins with Infantile Systemic Hyalinosis: Case study and review of literature. J Orthop Case Re  2016;6: 69-71
  7. Narayanan DL, Phadke SR. Infantile systemic hyalinosis with mutation in ANTXR2. Indian J Pediatr. 2016;83:1356-7.
  8. Koonuru MK, Venugopal SP. Infantile systemic hyalinosis in identical twins. Intractable Rare Dis Res. 2015;4:210-213.
  9. Shin HT, Paller A, Hoganson G, Willner JP, Chang MW, Orlow SJ. Infantile systemic hyalinosis. J Am Acad Dermatol. 2004;50(2 suppl):S61-S64. 
  10. Glover MT, Lake BD, Atherton DJ. Clinical, histologic, and ultrastructural findings in two cases of infantile systemic hyalinosis. Pediatr Dermatol 1992;9:255-8.
  11. Rashmi MV, Geetha JP, Srinivas Arava NM, Kodandaswamy CR. Juvenile Hyaline Fibromatosis (JHF): a rare case with recurrence. J Clin Diagn Res 2014 ;8:161.
  12. Denadai R, Raposo‐Amaral CE, Bertola D, Kim C, Alonso N, Hart T, Han S, Stelini RF, Buzzo CL, Raposo‐Amaral CA, Hart PS. Identification of 2 novel ANTXR2 mutations in patients with hyaline fibromatosis syndrome and proposal of a modified grading system. Am J Med Genet Part A. 2012;158:732-42 
  13. Huang YC, Xiao YY, Zheng YH, Jang W, Yang YL, Zhu XJ. Infantile systemic hyalinosis: a case report and mutation analysis in a Chinese infant. Br J Dermatol.. 2007;156:602-4.
  14. Finlay AY, Ferguson SD, Holt PJ. Juvenile hyaline fibromatosis. Br J Dermatol 1983;108:609‑16.
  15. Mantri MD, Pradeep MM, Kalpesh PO, Pranavsinh RJ. Hyaline fibromatosis syndrome: A rare inherited disorder. Indian J Dermatol.. 2016;61:580.
  16. Momin YA, Bharambe BM, D`Costa G. Juvenile hyaline fibromatosis: A rare lesion. Indian J Pathol Microbiol. 2011;54:838-839.
  17. Krishnamurthy J, Dalal BS, Sunila MV. Juvenile hyaline fibromatosis. Indian J Dermatol 2011 6:731
  18. Mancini GM, Stojanov L, Willemsen R, Kleijer WJ, Huijmans JG, Van Diggelen OP, De Klerk JB, Vuzevski VD, Oranje AP. Juvenile hyaline fibromatosis: clinical heterogeneity in three patients. Dermatology. 1999;198:18-25